01 72Boehringer Ingelheim (Canada) Ltd.
01 22435730
02 22496249
03 102557801
04 102606650
05 22651019
06 42696558
07 22738367
08 42751833
09 22751834
10 22752434
11 102752435
12 62776288
13 82813661
14 62908635
15 22909728
01 14EMPAGLIFLOZIN
02 22EMPAGLIFLOZIN | LINAGLIPTIN
03 36EMPAGLIFLOZIN | METFORMIN HYDROCHLORIDE
01 72TABLET
01 22022-02-21
02 22023-08-18
03 102025-03-11
04 102026-05-02
05 22027-05-03
06 42028-08-15
07 22029-10-15
08 182030-02-11
09 62030-10-01
10 82031-11-07
11 62034-04-03
12 22034-04-16
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Brand Name : JARDIANCE
Patent Number : 2557801
Filing Date : 2005-03-11
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Brand Name : JARDIANCE
Patent Number : 2606650
Filing Date : 2006-05-02
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Brand Name : JARDIANCE
Patent Number : 2606650
Filing Date : 2006-05-02
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Brand Name : JARDIANCE
Patent Number : 2557801
Filing Date : 2005-03-11
Strength per Unit : 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
Brand Name : SYNJARDY
Patent Number : 2557801
Filing Date : 2005-03-11
Strength per Unit : 5 mg / 500 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
Brand Name : SYNJARDY
Patent Number : 2606650
Filing Date : 2006-05-02
Strength per Unit : 5 mg / 500 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
Brand Name : SYNJARDY
Patent Number : 2557801
Filing Date : 2005-03-11
Strength per Unit : 5 mg / 850 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
Brand Name : SYNJARDY
Patent Number : 2606650
Filing Date : 2006-05-02
Strength per Unit : 5 mg / 850 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
Brand Name : SYNJARDY
Patent Number : 2557801
Filing Date : 2005-03-11
Strength per Unit : 5 mg / 1000 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-03-11
Date Granted : 2013-06-25
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE
Brand Name : SYNJARDY
Patent Number : 2606650
Filing Date : 2006-05-02
Strength per Unit : 5 mg / 1000 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-05-02
Date Granted : 2014-02-11
